---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-007222"
form_type: "8-K"
ticker: "HEPA"
cik: "0001583771"
company_name: "Hepion Pharmaceuticals, Inc."
filed_at: "2024-02-20T23:59:59+00:00"
generated_at: "2026-06-05T23:05:14.470273+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Chairman Gary Jacob resigns from Hepion board; John Brancaccio appointed Chairman

## Summary
- Dr. Gary Jacob resigned as Chairman and from the Board on February 20, 2024, for personal reasons.
- Board appointed John Brancaccio as new Chairman effective immediately.
- John Cavan continues as Interim CEO and CFO.

## SEC filing metadata
- accession: 0001493152-24-007222
- form_type: 8-K
- ticker: HEPA
- cik: 0001583771
- company_name: Hepion Pharmaceuticals, Inc.
- filed_at: 2024-02-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583771/000149315224007222/0001493152-24-007222-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583771/000149315224007222/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-007222
- JSON: https://secwatch.observer/filing/0001493152-24-007222.json
- Plain text: https://secwatch.observer/filing/0001493152-24-007222.txt

## Key facts
- Executive change
  John Brancaccio was appointed as Chairman at Hepion Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Chairman
  source text: Dr. Jacob was Chairman of the Company and the Board of Directors appointed John Brancaccio as Chairman.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1583771/000149315224007222/0001493152-24-007222-index.htm
- Executive change
  Gary Jacob resigned as Chairman of the Board at Hepion Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Chairman of the Board
  source text: On February 20, 2024, Dr. Gary Jacob resigned from the Board of Directors of Hepion Pharmaceuticals, Inc. (the “Company”) for personal reasons.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1583771/000149315224007222/0001493152-24-007222-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.